The Year's New Drugs and Biologics - 2008

Drug News and Perspectives

Volumn 22, Issue 1, 2009, Pages 7-29

  Graul, Ann I ^a   Revel, Laura ^a   Borrionuevo, Meritxell ^a   Cruces, Elisabet ^a   Rosa, Esmeralda ^a   Vergés, Clara ^a   Lupone, Becky ^a   Diaz, Núria ^a   Castañer, Rosa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; ALVIMOPAN; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ATLIZUMAB; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CLEVIDIPINE BUTYRATE; CLEVIPREX; COLESEVELAM; CONTRAST MEDIUM; DABIGATRAN ETEXILATE; DERMATOLOGICAL AGENT; DESVENLAFAXINE; FESOTERODINE; GASTROINTESTINAL AGENT; HARKOSERIDE; HEMATOLOGIC AGENT; HORMONE DERIVATIVE; IMMUNOMODULATING AGENT; LIDOCAINE; PIRESPA; PIRFENIDONE; PSYCHOTROPIC AGENT; RESPIRATORY TRACT AGENT; SITAFLOXACIN; STELARA; TAPENTADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; URINARY TRACT AGENT; USTEKINUMAB;

ADJUVANT THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG APPROVAL; DRUG INDICATION; DRUG INFORMATION; DRUG MARKETING; DRUG MECHANISM; DRUG METABOLISM; DRUG RESEARCH; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; GASTROINTESTINAL DISEASE; GLAUCOMA; HUMAN; IMMUNE DEFICIENCY; MAJOR DEPRESSION; MUSCULOSKELETAL DISEASE; OVERACTIVE BLADDER; PAIN; SOLID TUMOR; UNSPECIFIED SIDE EFFECT; VASCULAR ACCESS; VENOUS THROMBOEMBOLISM;

EID: 62649101241     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2009.22.1.1303754     Document Type: Article

References (3)

1. Boomershine, C.S. First pregabalin and now duloxetine for fibromyalgia syndrome: Closer to a brave new world? Nat Clin Pract Rheumatol 2008, 4(12): 636-7.
2. Erickson-Miller, C.L., Delorme, E., Tian, S.S. et al. Preclinical activity of eltrombopag (SB-497115), an oral, non-peptide thrombopoietin receptor agonist. Stem Cells. 2008 Nov 26.
3. Jenkins, J.M., Williams, D., Deng, Y., Uhl, J., Kitchen, V., Collins, D. and Erickson-Miller, C.L. Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 2007, 109(11): 4739-41.